Table 1.
Survey Participants use of Telehealth.
| Number of Telehealth Sessions | ||||
|---|---|---|---|---|
| N (%) | P-value c | |||
| Characteristic | None | 1–5 times | 6 + times | |
| Overall | 90 (28.4%) | 151 (47.6%) | 76 (24.0%) | |
| Gender a | ||||
| Female | 57 (27.7%) | 109 (52.9%) | 40 (19.4%) | .0110 |
| Male | 32 (29.4%) | 41 (37.6%) | 36 (33.0%) | |
| Other | 0 (0.0%) | 1 (100.0%) | 0 (0.0%) | |
| Prefer not to answer | 1 (100.0%) | 0 (0.0%) | 0 (0.0%) | |
| Age | ||||
| 18–4 | 5 (20.0%) | 5 (20.0%) | 15 (60.0%) | <.001 |
| 35–49 | 16 (16.2%) | 48 (48.5%) | 35 (35.4%) | |
| 50–64 | 37 (28.5%) | 73 (56.2%) | 20 (15.4%) | |
| 65 + | 32 (50.8%) | 25 (39.7%) | 6 (9.5%) | |
| Race/Ethnicity b | ||||
| Hispanic | 3(6%) | 15 (30%) | 32 (64%) | <.001 |
| Non-Hispanic White | 73 (33.3%) | 111 (50.7%) | 35 (16.0%) | |
| Non-Hispanic Black | 9 (29.0%) | 17 (54.8%) | 5 (16.1%) | |
| Other Non-Hispanic/ multiracial/other | 5 (31.3%) | 7 (43.8%) | 4 (25.0%) | |
| Cancer stage at diagnosis | ||||
| Stage 0/1 | 19 (42.2%) | 25 (55.6%) | 1 (2.2%) | <.001 |
| Stage II | 15 (23.4%) | 28 (43.8%) | 21 (32.8%) | |
| Stage III | 14 (17.1%) | 40 (48.8%) | 28 (34.1%) | |
| Stage IV | 21 (23.6%) | 46 (51.7%) | 22 (24.7%) | |
| Don't know/other | 21 (56.8%) | 12 (32.4%) | 4 (10.8%) | |
Note: aAnswers other than male and female were excluded for statistical testing.
b
For statistical testing, categories were collapsed into three categories: (1) Hispanic, (2) Non-Hispanic White, and (3) Non-Hispanic Black/Asian, American Indian, Native Hawaiians and Pacific Islanders/Other/Multiracial.
c
Statistical tests conducted were chi-square tests.